Open AccessThe Use of Erdafitinib in Treating Urothelial Carcinoma
Author(s) -
Pippa Wysong
Publication year - 2019
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000586268.14895.20
Subject(s) - medicine , bladder cancer , oncology , tyrosine kinase inhibitor , cancer , carcinoma , cancer research , metastatic urothelial carcinoma , fibroblast growth factor receptor , fibroblast growth factor , urothelial carcinoma , receptor